Chromatography Solvents Market has accounted for USD 101.7 billion in 2016 and is expected to reach USD 205.1 billion by 2024 at 9.2% by 2024.

DALLAS, TEXAS, UNITED STATES, June 16, 2017 /EINPresswire.com/ -- Global Topical Drug Delivery Market, By Product Type {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches, Gels)}; End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail); Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Ask for Sample of the report: http://databridgemarketresearch.com/request-a-sample/?chalet=Global%20Topical%20Drug%20Delivery%20Market

Segmentation:

By Product Type:

• Topical
 Solid
 Liquid
 Semi-Solid
• Transdermal
 Patches
 Gels

By End-User:

• Hospitals
• Clinics
• Home Healthcare
• Diagnostic Centers

By Distribution Channel:

• Direct Tenders
• Retail

Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.


Read More on the market trends of Global Topical Drug Delivery Market: http://databridgemarketresearch.com/global-topical-drug-delivery-market-poised-grow-9-2/


The major players in the topical drug delivery prescription drugs are Galderma Pharma, S.A., Allergen Plc. Kaken Pharmaceuticals, Co., Ltd, Pfizer, Bayer AG, 3M, Hisamitsu Pharmaceuticals, Co., Inc., Abbvie, Inc., Valeant Pharmaceuticals, Antares Pharma among others. Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.

Some Recent Developments:

• Galderma Pharma S.A.
Galderma Pharma S.A. was incorporated in 1981, as a joint between Nestle and L’Oreal.

• Bayer AG
Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services.

• Valeant Pharmaceuticals International, Inc.
Founded in 1994 and headquartered in Quebec, Canada, Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics.

Purchase Request: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/

Table Of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE
2.4. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL TOPICAL DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE
6.2.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE
7. TOPICAL DRUG DELIVERY MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. HOME HEALTHCARE
7.4. CLINICS
7.5. DIAGNOSTIC CENTERS
7.6. OTHERS
8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. HOSPITAL PHARMACIES
8.3. PHARMACY STORES
8.4. DIRECT TENDERS
8.5. ONLINE PHARMACY
9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.2. EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.4. LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.4. APAC TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.10. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES
11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)
11.2. CRESCITA THERAPEUTICS
11.3. GALDERMA S.A.
11.4. BIOFARMITALIA S.R.L
11.5. PHARMATEK LABORATORIES, INC.
11.6. STIEFEL LABORATORIES, INC.
11.7. TAPEMARK
11.8. NITTO DENKO CORPORATION
11.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
11.11. MYLAN PHARMACEUTICALS INC.
11.12. HISAMITSU PHARMACEUTICAL CO., INC.
11.13. THERASOLVE NV.
11.14. SAMYANG BIOPHARMACEUTICALS CORPORATION
11.15. LOHMANN THERAPIE-SYSTEME AG
11.16. PROSOLLUS PHARMACEUTICALS
11.17. EASTON PHARMACEUTICALS INC.
11.18. ANTARES PHARMA, INC.
11.19. ENDO PHARMACEUTICALS INC.
11.20. TRANSDERMAL TECHNOLOGIES, INC.
11.21. SHEFFIELD PHARMACEUTICALS, INC.
11.22. SOLVAY
11.23. 3M DRUG DELIVERY SYSTEMS

Varsha Chaudhari
Data Bridge Market Research Private Ltd.
+1-888-387-2818
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.